

- Mar 4
- 3 min
Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer


- Mar 2
- 6 min
Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

- Feb 24
- 5 min
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million


- Feb 13
- 2 min
Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms


- Feb 1
- 4 min
Panbela prices $15 million public offering


- Jan 18
- 2 min
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab


- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

- Dec 27, 2022
- 2 min
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies


- Dec 22, 2022
- 4 min
University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera


- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering


- Nov 5, 2022
- 3 min
H.I.G. Capital acquires leading global clinical research organization Celerion


- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development


- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology


- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects


- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease


- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials


- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies